Ancillary Testing in Lung Cancer Diagnosis
The pathologic diagnosis of lung cancer historically has relied primarily on morphologic features of tumors in histologic sections. With the emergence of new targeted therapies, the pathologist is called upon increasingly to provide not only accurate typing of lung cancers, but also to provide progn...
Saved in:
Main Authors: | William Dubinski, Natasha B. Leighl, Ming-Sound Tsao, David M. Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Pulmonary Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/249082 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ancillary tests for brain death
by: Shyam Duvuru, et al.
Published: (2025-01-01) -
The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer
by: Barbara Melosky, et al.
Published: (2025-01-01) -
Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada
by: Lara Chayab, et al.
Published: (2024-12-01) -
Cutting the Difficult Papilla: Ancillary Techniques in the Performance of Endoscopic Sphincterotomy
by: Claude Liguory, et al.
Published: (1990-01-01) -
Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research
by: Cheol-Kyu Park, MD, PhD, et al.
Published: (2025-03-01)